Giardiasis: An Overview

Author(s): Alexander K.C. Leung*, Amy A.M. Leung, Alex H.C. Wong, Consolato M. Sergi, Joseph K.M. Kam

Journal Name: Recent Patents on Inflammation & Allergy Drug Discovery

Volume 13 , Issue 2 , 2019

Become EABM
Become Reviewer

Abstract:

Background: Giardiasis is an important cause of waterborne and foodborne diarrhea, daycare center outbreaks, and traveler's diarrhea.

Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of giardiasis.

Methods: A PubMed search was completed in Clinical Queries using the key terms “giardiasis”, "Giardia lamblia", "Giardia duodenalis" and "Giardia intestinalis". The search strategy included metaanalyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to the English literature. Patents were searched using the key term “giardiasis” from www.freepatentsonline.com.

Results: Giardiasis is caused by the protozoan parasite Giardia lamblia. The parasite is transmitted by the fecal-oral route, frequently through ingestion of contaminated water and food or person-to person transmission. Risk factors for infection include children in day-care settings, child-care workers, institutionalized individuals, travelers in endemic areas, ingestion of contaminated or recreational water, immunodeficiency, cystic fibrosis, and oral-anal sex. Approximately 50 to 75% of infected children are asymptomatic. Other children present acute or chronic diarrhea. Direct fluorescent antibody tests that detect intact organisms, enzyme immunoassays that detect soluble antigens, and multiplex real-time polymerase chain reaction assays that detect specific genes of the parasite in stool samples have improved sensitivity and specificity compared with microscopic examination of stool specimens for the detection of Giardia trophozoites or cysts. Drugs used in the treatment of symptomatic giardiasis are reviewed in this study. Moreover, recent patents related to the management of giardiasis are also discussed.

Conclusion: Metronidazole, tinidazole, and nitazoxanide are drugs of choice. Resistance to common antigiardial drugs has increased in recent years, therefore, the search for new molecular targets for antigiardial drugs is urgently needed. In general, treatment of asymptomatic carriers is not recommended. Purification of water supply is an important preventive measure.

Keywords: Antigiardial drugs, diarrhea, foodborne, Giardia duodenalis, Giardia intestinalis, Giardia lamblia, parasites, waterborne.

[1]
Leung AK. Giardiasis. In: Leung AK, ed. Common Problems in Ambulatory Pediatrics: Specific Clinical Problems, Volume 2. New York: Nova Science Publishers, Inc. 2011; 39-42.
[2]
Leung AK, Robson WL, Davies HD. Traveler’s diarrhea. Adv Ther 2006; 23(4): 519-27.
[http://dx.doi.org/10.1007/BF02850040] [PMID: 17050494]
[3]
Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium join the ‘Neglected Diseases Initiative’. Trends Parasitol 2006; 22(5): 203-8.
[http://dx.doi.org/10.1016/j.pt.2006.02.015] [PMID: 16545611]
[4]
Daly ER, Roy SJ, Blaney DD, Manning JS, Hill VR, Xiao L, et al. Outbreak of giardiasis associated with a community drinking-water source. Epidemiol Infect 2010; 138(4): 491-500.
[http://dx.doi.org/10.1017/S0950268809990744] [PMID: 19751538]
[5]
Eisenstein L, Bodager D, Ginzl D. Outbreak of giardiasis and cryptosporidiosis associated with a neighborhood interactive water fountain - Florida, 2006. J Environ Health 2008; 71(3): 18-22.
[PMID: 18990929]
[6]
Cama VA, Mathison BA. Infections by intestinal Coccidia and Giardia duodenalis. Clin Lab Med 2015; 35(2): 423-44.
[http://dx.doi.org/10.1016/j.cll.2015.02.010] [PMID: 26004650]
[7]
Leder K, Weller PF. Giardiasis: Epidemiology, clinical manifestations, and diagnosis. In: UpToDate. (Accessed on: March 15, 2019).
[8]
Cacciò SM, Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol 2008; 160(2): 75-80.
[http://dx.doi.org/10.1016/j.molbiopara.2008.04.006] [PMID: 18501440]
[9]
Fink MY, Singer SM. The intersection of immune responses, microbiota, and pathogenesis in giardiasis. Trends Parasitol 2017; 33(11): 901-13.
[http://dx.doi.org/10.1016/j.pt.2017.08.001] [PMID: 28830665]
[10]
Halliez MC, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013; 19(47): 8974-85.
[http://dx.doi.org/10.3748/wjg.v19.i47.8974] [PMID: 24379622]
[11]
Roxström-Lindquist K, Palm D, Reiner D, Ringqvist E, Svard SG. Giardia immunity - An update. Trends Parasitol 2006; 22(1): 26-31.
[http://dx.doi.org/10.1016/j.pt.2005.11.005] [PMID: 16303332]
[12]
Tandukar S, Sherchand JB, Xue J, Uprety S, Sherchan SP, Bhandari D, et al. Prevalence and associated risk factors of Giardia duodenalis infection among school-going children in Nepal. Parasitol Res 2018; 117(1): 287-93.
[http://dx.doi.org/10.1007/s00436-017-5706-5] [PMID: 29218443]
[13]
Beer KD, Collier SA, Du F, Gargano JW. Giardiasis diagnosis and treatment practices among commercially insured persons in the United States. Clin Infect Dis 2017; 64(9): 1244-50.
[http://dx.doi.org/10.1093/cid/cix138] [PMID: 28207070]
[14]
Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne illness acquired in the United States - Unspecified agents. Emerg Infect Dis 2011; 17(1): 16-22.
[http://dx.doi.org/10.3201/eid1701.P21101] [PMID: 21192849]
[15]
Giardia intestinalis (formerly Giardia lamblia and Giardia duodenalis) infections. Red Book: 2018 Report of the Committee on Infectious Diseases 31st ed. 2018; 352-5.
[16]
Currie SL, Stephenson N, Palmer AS, Jones BL, Hawkins G, Alexander CL. Under-reporting giardiasis: Time to consider the public health implications. Epidemiol Infect 2017; 145(14): 3007-11.
[http://dx.doi.org/10.1017/S0950268817001959] [PMID: 28879824]
[17]
Lebwohl B, Deckelbaum RJ, Green PH. Giardiasis. Gastrointest Endosc 2003; 57(7): 906-13.
[http://dx.doi.org/10.1016/S0016-5107(03)70028-5] [PMID: 12776040]
[18]
Minetti C, Chalmers RM, Beeching NJ, Probert C, Lamden K. Giardiasis. BMJ 2016; 355: i5369.
[http://dx.doi.org/10.1136/bmj.i5369] [PMID: 27789441]
[19]
Adam EA, Yoder JS, Gould LH, Hlavsa MC, Gargano JW. Giardiasis outbreaks in the United States, 1971-2011. Epidemiol Infect 2016; 144(13): 2790-801.
[http://dx.doi.org/10.1017/S0950268815003040] [PMID: 26750152]
[20]
Einarsson E, Ma’ayeh S, Svärd SG. An up-date on Giardia and giardiasis. Curr Opin Microbiol 2016; 34: 47-52.
[http://dx.doi.org/10.1016/j.mib.2016.07.019] [PMID: 27501461]
[21]
Escobedo AA, Almirall P, Hanevik K, Cimerman S, Rodríguez-Morales AJ, et al. Giardiasis: A diagnosis that should be considered regardless of the setting. Epidemiol Infect 2018; 146(10): 1216-8.
[http://dx.doi.org/10.1017/S0950268818001504] [PMID: 29886858]
[22]
Beiromvand M, Mirrezaie E, Mirzavand S. Foodborne giardiasis: Is there any relationship between food handlers and transmission of giardia duodenalis? Infect Disord Drug Targets 2017; 17(2): 72-6.
[http://dx.doi.org/10.2174/1871526517666170111105040] [PMID: 28079004]
[23]
Pakianathan MR, McMillan A. Intestinal protozoa in homosexual men in Edinburgh. Int J STD AIDS 1999; 10(12): 780-4.
[http://dx.doi.org/10.1258/0956462991913547] [PMID: 10639057]
[24]
Esfandiari A, Swartz J, Teklehaimanot S. Clustering of giardiasis among AIDS patients in Los Angeles County. Cell Mol Biol 1997; 43(7): 1077-83.
[PMID: 9449541]
[25]
National Institute of Infectious Diseases. Japan. Cryptosporidiosis and giardiasis as of July 2014. IASR 2014; 35: 185-6.
[26]
Angarano G, Maggi P, Di Bari MA, Larocca AM, Congedo P, Di Bari C, et al. Giardiasis in HIV: A possible role in patients with severe immune deficiency. Eur J Epidemiol 1997; 13(4): 485-7.
[http://dx.doi.org/10.1023/A:1007375421908] [PMID: 9258558]
[27]
Escobedo AA, Almirall P, Alfonso M, Cimerman S, Chacín-Bonilla L. Sexual transmission of giardiasis: A neglected route of spread? Acta Trop 2014; 132: 106-11.
[http://dx.doi.org/10.1016/j.actatropica.2013.12.025] [PMID: 24434784]
[28]
Hlavsa MC, Watson JC, Beach MJ. Giardiasis surveillance - United States, 1998-2002. MMWR Surveill Summ 2005; 54(1): 9-16.
[PMID: 15674189]
[29]
Otsubo K, Sakaki-Nakatsubo H, Taneichi H, Nomura K, Miyawaki T, Tokoro M, et al. Giardiasis in a patient undergoing chemotherapy for retinoblastoma and acute myelogenous leukemia. Pediatr Int 2013; 55(4): 524-7.
[http://dx.doi.org/10.1111/ped.12078] [PMID: 23910805]
[30]
Saifi ES, Gavazzi A, Spandrio S. Giardiasis and subsequent diagnosis of HIV infection in a patient with persistent diarrhoea: A case report. Infez Med 2018; 26(1): 89-92.
[PMID: 29525804]
[31]
Naz A, Nawaz Z, Rasool MH, Zahoor MA. Cross-sectional epidemiological investigations of Giardia lamblia in children in Pakistan. Sao Paulo Med J 2018; 136(5): 449-53.
[PMID: 30570096]
[32]
Tůmová P, Mazánek L, Lecová L, Dluhošová J, Typovská H, Kotrašová V, et al. A natural zoonotic giardiasis: Infection of a child via Giardia cysts in pet chinchilla droppings. Parasitol Int 2018; 67(6): 759-62.
[http://dx.doi.org/10.1016/j.parint.2018.07.010] [PMID: 30053544]
[33]
Leung AK, Sauve RS. Breast is best for babies. J Natl Med Assoc 2005; 97(7): 1010-9.
[PMID: 16080672]
[34]
Leung AK, Robson WL. Breastfeeding. In: Cater LV, ed. Child Nutrition Research Advances. New York: Nova Science Publishers, Inc. 2007; 1-36.
[35]
Burnett MW. Giardiasis. J Spec Oper Med Spring 2018; 18(1): 106-7.
[PMID: 29533443]
[36]
Zahedi A, Field D, Ryan U. Molecular typing of Giardia duodenalis in humans in Queensland - First report of Assemblage E. Parasitology 2017; 144(9): 1154-61.
[http://dx.doi.org/10.1017/S0031182017000439] [PMID: 28482937]
[37]
Kucik CJ, Martin GI, Sortor BV. Common intestinal parasites. Am Fam Physician 2004; 69(5): 1161-8.
[PMID: 15023017]
[38]
Kalyoussef S, Goldman D. Giardiasis and cryptosporidiosis. Pediatr Rev 2010; 31(2): 81-2.
[http://dx.doi.org/10.1542/pir.31-2-81] [PMID: 20124279]
[39]
Robaei D, Vo-Robaei L, Bewes T, Terkasher B, Pitney M. Myocarditis in association with Giardia intestinalis infection. Int J Cardiol 2014; 177(3): e142-4.
[http://dx.doi.org/10.1016/j.ijcard.2014.09.050] [PMID: 25294176]
[40]
Bartelt LA. Giardiasis: Treatment and prevention. In: Post TW, ed. UpToDate. Waltham, MA. (Accessed on: March 15, 2019).s
[41]
Dawson D. Foodborne protozoan parasites. Int J Food Microbiol 2005; 103(2): 207-27.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2004.12.032] [PMID: 16083823]
[42]
Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am 2006; 35(2): 291-314.
[http://dx.doi.org/10.1016/j.gtc.2006.03.006] [PMID: 16880067]
[43]
Liu J, Ma’ayeh S, Peirasmaki D, Lundström-Stadelmann B, Hellman L, Svärd SG. Secreted Giardia intestinalis cysteine proteases disrupt intestinal epithelial cell junctional complexes and degrade chemokines. Virulence 2018; 9(1): 879-94.
[http://dx.doi.org/10.1080/21505594.2018.1451284] [PMID: 29726306]
[44]
Lopez-Romero G, Quintero J, Astiazarán-García H, Velazquez C. Host defences against Giardia lamblia. Parasite Immunol 2015; 37(8): 394-406.
[http://dx.doi.org/10.1111/pim.12210] [PMID: 26072999]
[45]
Heagley DE, Jakate S. Giardiasis confined to the terminal ileum. Clin Gastroenterol Hepatol 2012; 10(2): A28.
[http://dx.doi.org/10.1016/j.cgh.2011.08.006] [PMID: 21854737]
[46]
Adam RD. Biology of Giardia lamblia. Clin Microbiol Rev 2001; 14(3): 447-75.
[http://dx.doi.org/10.1128/CMR.14.3.447-475.2001] [PMID: 11432808]
[47]
Pickering LK, Woodward WE, DuPont HL, Sullivan P. Occurrence of Giardia lamblia in children in day care centers. J Pediatr 1984; 104(4): 522-6.
[http://dx.doi.org/10.1016/S0022-3476(84)80540-5] [PMID: 6707812]
[48]
Pietrzak A, Chodorowska G, Urban J, Bogucka V, Dybiec E. Cutaneous manifestation of giardiasis - Case report. Ann Agric Environ Med 2005; 12(2): 299-303.
[PMID: 16457489]
[49]
Almirall P, Núñez FA, Bello J, González OM, Fernández R, Escobedo AA. Abdominal pain and asthenia as common clinical features in hospitalized children for giardiasis. Acta Trop 2013; 127(3): 212-5.
[http://dx.doi.org/10.1016/j.actatropica.2013.05.005] [PMID: 23692887]
[50]
Kohli A, Bushen OY, Pinkerton RC, Houpt E, Newman RD, Sears CL, et al. Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in Brazilian children. Trans R Soc Trop Med Hyg 2008; 102(7): 718-25.
[http://dx.doi.org/10.1016/j.trstmh.2008.03.002] [PMID: 18485429]
[51]
LoGalbo PR, Sampson HA, Buckley RH. Symptomatic giardiasis in three patients with X-linked agammaglobulinemia. J Pediatr 1982; 101(1): 78-80.
[http://dx.doi.org/10.1016/S0022-3476(82)80188-1] [PMID: 7201017]
[52]
Petri WA. Treatment of giardiasis. Curr Treat Options Gastroenterol 2005; 8(1): 13-7.
[http://dx.doi.org/10.1007/s11938-005-0047-3] [PMID: 15625030]
[53]
Silva RK, Pacheco FT, Martins AS, Menezes JF, Costa-Ribeiro H Jr, Ribeiro TC, et al. Performance of microscopy and ELISA for diagnosing Giardia duodenalis infection in different pediatric groups. Parasitol Int 2016; 65(6 Pt A): 635-40.
[http://dx.doi.org/10.1016/j.parint.2016.08.012] [PMID: 27586394]
[54]
Shin JH, Lee SE, Kim TS, Ma DW, Cho SH, Chai JY, et al. Development of molecular diagnosis using multiplex real-time PCR and T4 phage internal control to simultaneously detect Cryptosporidium parvum, Giardia lamblia, and Cyclospora cayetanensis from human stool samples. Korean J Parasitol 2018; 56(5): 419-27.
[http://dx.doi.org/10.3347/kjp.2018.56.5.419] [PMID: 30419727]
[55]
Mero S, Kirveskari J, Antikainen J, Ursing J, Rombo L, Kofoed PE, et al. Multiplex PCR detection of Cryptosporidium sp., Giardia lamblia and Entamoeba histolytica directly from dried stool samples from Guinea-Bissauan children with diarrhoea. Infect Dis 2017; 49(9): 655-63.
[http://dx.doi.org/10.1080/23744235.2017.1320728] [PMID: 28446068]
[56]
Parčina M, Reiter-Owona I, Mockenhaupt FP, Vojvoda V, Gahutu JB, Hoerauf A, et al. Highly sensitive and specific detection of Giardia duodenalis, Entamoeba histolytica, and Cryptosporidium spp. in human stool samples by the BD MAX™ Enteric Parasite Panel. Parasitol Res 2018; 117(2): 447-51.
[http://dx.doi.org/10.1007/s00436-017-5720-7] [PMID: 29260297]
[57]
Soares R, Tasca T. Giardiasis: An update review on sensitivity and specificity of methods for laboratorial diagnosis. J Microbiol Methods 2016; 129: 98-102.
[http://dx.doi.org/10.1016/j.mimet.2016.08.017] [PMID: 27546714]
[58]
Mayer CL, Palmer CJ. Evaluation of PCR, nested PCR, and fluorescent antibodies for detection of Giardia and Cryptosporidium species in wastewater. Appl Environ Microbiol 1996; 62(6): 2081-5.
[PMID: 8787406]
[59]
Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther 2005; 22(5): 476-87.
[http://dx.doi.org/10.1007/BF02849868] [PMID: 16418157]
[60]
Farthing MJ, Mata L, Urrutia JJ, Kronmal RA. Natural history of Giardia infection of infants and children in rural and its impact on physical growth. Am J Clin Nutr 1986; 43(3): 395-405.
[http://dx.doi.org/10.1093/ajcn/43.3.395] [PMID: 3953479]
[61]
Beatty JK, Akierman SV, Motta JP, Muise S, Workentine ML, Harrison JJ, et al. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. Int J Parasitol 2017; 47(6): 311-26.
[http://dx.doi.org/10.1016/j.ijpara.2016.11.010] [PMID: 28237889]
[62]
Bansal R, Ghevariya V, Aron J, Rajnish I, Tiba M. Giardiasis and nodular lymphoid hyperplasia of the duodenum. Am J Gastroenterol 2016; 111(4): 455.
[http://dx.doi.org/10.1038/ajg.2015.299] [PMID: 27125704]
[63]
Baran B, Gulluoglu M, Akyuz F. Nodular lymphoid hyperplasia of duodenum caused by giardiasis. Clin Gastroenterol Hepatol 2013; 11(10): A22.
[http://dx.doi.org/10.1016/j.cgh.2012.12.019] [PMID: 23333704]
[64]
Koot BG, ten Kate FJ, Juffrie M, Rosalina I, Taminiau JJ, Benninga MA. Does Giardia lamblia cause villous atrophy in children?: A retrospective cohort study of the histological abnormalities in giardiasis. J Pediatr Gastroenterol Nutr 2009; 49(3): 304-8.
[http://dx.doi.org/10.1097/MPG.0b013e31818de3c4] [PMID: 19525873]
[65]
Kanar O, Nakshabendi R, Jiwani F, Liu Y, Allsopp W, Berry AC. Giardiasis: A malignant mimicker? Intern Emerg Med 2016; 11(1): 149-51.
[http://dx.doi.org/10.1007/s11739-015-1267-8] [PMID: 26055831]
[66]
Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: A follow-up study. Lancet 2002; 359(9306): 564-71.
[http://dx.doi.org/10.1016/S0140-6736(02)07744-9] [PMID: 11867110]
[67]
Botero-Garcés JH, García-Montoya GM, Grisales-Patiño D, Aguirre-Acevedo DC, Alvarez-Uribe MC. Giardia intestinalis and nutritional status in children participating in the complementary nutrition program, Antioquia, Colombia, May to October 2006. Rev Inst Med Trop São Paulo 2009; 51(3): 155-62.
[http://dx.doi.org/10.1590/S0036-46652009000300006] [PMID: 19551290]
[68]
Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, et al. Early childhood diarrhea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg 2002; 66(5): 590-3.
[http://dx.doi.org/10.4269/ajtmh.2002.66.590] [PMID: 12201596]
[69]
Robertson LJ, Hanevik K, Escobedo AA, Mørch K, Langeland N. Giardiasis - Why do the symptoms sometimes never stop? Trends Parasitol 2010; 26(2): 75-82.
[http://dx.doi.org/10.1016/j.pt.2009.11.010] [PMID: 20056486]
[70]
Khalil Q, Anusionwu C, Agrawal S. Giardiasis - An unusual cause of iron deficiency anemia. J Ark Med Soc 2012; 108(13): 294-6.
[PMID: 22799132]
[71]
Leung AK, Chan KW. Iron deficiency anemia. Adv Pediatr 2001; 48: 385-408.
[PMID: 11480764]
[72]
Quihui L, Morales GG, Méndez RO, Leyva JG, Esparza J, Valencia ME. Could giardiasis be a risk factor for low zinc status in school children from North Western Mexico? A cross-sectional study with longitudinal follow-up. BMC Public Health 2010; 10(1): 85.
[http://dx.doi.org/10.1186/1471-2458-10-85] [PMID: 20170531]
[73]
Escobedo AA, Almirall P, Cimerman S, Rodríguez-Morales AJ. Sequelae of giardiasis: An emerging public health concern. Int J Infect Dis 2016; 49: 202-3.
[http://dx.doi.org/10.1016/j.ijid.2016.06.008] [PMID: 27312579]
[74]
Halliez MC, Motta JP, Feener TD, Guérin G, LeGoff L, François A, et al. Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2016; 310(8): G574-85.
[http://dx.doi.org/10.1152/ajpgi.00144.2015] [PMID: 26744469]
[75]
Hanevik K, Kristoffersen E, Mørch K, Rye KP, Sørnes S, Svärd S, et al. Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. BMC Immunol 2017; 18(1): 5.
[http://dx.doi.org/10.1186/s12865-017-0190-3] [PMID: 28129747]
[76]
Mørch K, Hanevik K, Rivenes AC, Bødtker JE, Næss H, Stubhaug B, et al. Chronic fatigue syndrome 5 years after giardiasis: Differential diagnoses, characteristics and natural course. BMC Gastroenterol 2013; 13: 28.
[http://dx.doi.org/10.1186/1471-230X-13-28] [PMID: 23399438]
[77]
Nakao JH, Collier SA, Gargano JW. Giardiasis and subsequent irritable bowel syndrome: A longitudinal cohort study using health insurance data. J Infect Dis 2017; 215(5): 798-805.
[http://dx.doi.org/10.1093/infdis/jiw621] [PMID: 28329069]
[78]
Araki H, Shimizu S, Hayashi K, Yamada T, Kusakabe A, Kanie H, et al. Acute acalculous cholecystitis caused by Giardia lamblia. Intern Med 2017; 56(13): 1657-62.
[http://dx.doi.org/10.2169/internalmedicine.56.8087] [PMID: 28674353]
[79]
Cervelló A, Alfaro A, Chumillas MJ. Hypokalemic myopathy induced by Giardia lamblia. N Engl J Med 1993; 329(3): 210-1.
[http://dx.doi.org/10.1056/NEJM199307153290318] [PMID: 8515799]
[80]
Genovese A, Spadaro G, Santoro L, Gasparo Rippa P, Onorati AM, Marone G. Giardiasis as a cause of hypokalemic myopathy in congenital immunodeficiency. Int J Clin Lab Res 1996; 26(2): 132-5.
[http://dx.doi.org/10.1007/BF02592356] [PMID: 8856367]
[81]
Gheorghe C, Cotruta B, Becheanu G, Dumbrava M, Verban S. Giardia duodenalis associated with intestinal metaplasia of the stomach. J Gastrointestin Liver Dis 2017; 26(3): 221.
[PMID: 28922429]
[82]
Turnbull AM, Lin Z, Matthews BN. Severe bilateral anterior uveitis secondary to giardiasis, initially misdiagnosed as a side effect of metronidazole. Eye (Lond) 2013; 27(10): 1225-6.
[http://dx.doi.org/10.1038/eye.2013.145] [PMID: 23827978]
[83]
Chow CM, Leung AK, Hon KL. Acute gastroenteritis: From guidelines to real life. Clin Exp Gastroenterol 2010; 3: 97-112.
[http://dx.doi.org/10.2147/CEG.S6554] [PMID: 21694853]
[84]
Issenman RM, Leung AK. Oral and intravenous rehydration of children. Can Fam Physician 1993; 39: 2129-36.
[PMID: 8219860]
[85]
Leung AK, Darling P, Auclair C. Oral rehydration therapy - A review. J R Soc Health 1987; 107(2): 64-7.
[http://dx.doi.org/10.1177/146642408710700210] [PMID: 3108503]
[86]
Leung AK, Robson WL. Acute diarrhea in children. What to do and what not to do. Postgrad Med 1989; 86(8): 167-74.
[http://dx.doi.org/10.1080/00325481.1989.11704505] [PMID: 2685791]
[87]
Granados CE, Reveiz L, Uribe LG, Criollo CP. Drugs for treating giardiasis. Cochrane Database Syst Rev 2012; 12CD007787
[PMID: 23235648]
[88]
Carter ER, Nabarro LE, Hedley L, Chiodini PL. Nitroimidazole-refractory giardiasis: A growing problem requiring rational solutions. Clin Microbiol Infect 2018; 24(1): 37-42.
[http://dx.doi.org/10.1016/j.cmi.2017.05.028] [PMID: 28624613]
[89]
Escobedo AA, Almirall P, González-Fraile E, Ballesteros J. Efficacy of mebendazole in paediatric patients with giardiasis: A systematic review and meta-analysis. Acta Trop 2018; 188: 50-7.
[http://dx.doi.org/10.1016/j.actatropica.2018.08.001] [PMID: 30092225]
[90]
Escobedo AA, Ballesteros J, González-Fraile E, Almirall P. A meta-analysis of the efficacy of albendazole compared with tinidazole as treatments for Giardia infections in children. Acta Trop 2016; 153: 120-7.
[http://dx.doi.org/10.1016/j.actatropica.2015.09.023] [PMID: 26476393]
[91]
Ozbilgin A, Ertan P, Yereli K, Tamay AT, Kurt O, Degerli K, et al. Giardiasis treatment in Turkish children with a single dose of ornidazole. Scand J Infect Dis 2002; 34(12): 918-20.
[http://dx.doi.org/10.1080/0036554021000026962] [PMID: 12587625]
[92]
Jarrad AM, Debnath A, Miyamoto Y, Hansford KA, Pelingon R, Butler MS, et al. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. Eur J Med Chem 2016; 120: 353-62.
[http://dx.doi.org/10.1016/j.ejmech.2016.04.064] [PMID: 27236016]
[93]
Almirall P, Escobedo AA, Ayala I, Alfonso M, Salazar Y, Cañete R, et al. Mebendazole compared with secnidazole in the treatment of adult giardiasis: A randomised, no-inferiority, open clinical trial. J Parasitol Res 2011; 2011636857
[http://dx.doi.org/10.1155/2011/636857] [PMID: 22174992]
[94]
Meltzer E, Lachish T, Schwartz E. Treatment of giardiasis after nonresponse to nitroimidazole. Emerg Infect Dis 2014; 20(10): 1742-4.
[http://dx.doi.org/10.3201/eid2010.140073] [PMID: 25271363]
[95]
Requena-Méndez A, Goñi P, Rubio E, Pou D, Fumadó V, Lóbez S, et al. The Use of Quinacrine in nitroimidazole-resistant Giardia Duodenalis: An old drug for an emerging problem. J Infect Dis 2017; 215(6): 946-53.
[http://dx.doi.org/10.1093/infdis/jix066] [PMID: 28453841]
[96]
Escobedo AA, Almirall P, Chirino E, Pacheco F, Duque A, Avila I. Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: A case series. Infez Med 2018; 6(4): 379-84.
[PMID: 30555145]
[97]
Cacopardo B, Patamia I, Bonaccorso V, Di Paola O, Bonforte S, Brancati G. Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis. Clin Ter 1995; 146(12): 761-7.
[PMID: 8681495]
[98]
Lopez-Velez R, Batlle C, Jiménez C, Navarro M, Norman F, Perez-Molina J. Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg 2010; 83(1): 171-3.
[http://dx.doi.org/10.4269/ajtmh.2010.09-0742] [PMID: 20595497]
[99]
Mørch K, Hanevik K, Robertson LJ, Strand EA, Langeland N. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. J Infect 2008; 56(4): 268-73.
[http://dx.doi.org/10.4269/ajtmh.2010.09-0742] [PMID: 20595497]
[100]
Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33(1): 22-8.
[http://dx.doi.org/10.1086/320886] [PMID: 11389490]
[101]
Escobedo AA, Lalle M, Hrastnik NI, Rodríguez-Morales AJ, Castro-Sánchez E, Cimerman S, et al. Combination therapy in the management of giardiasis: What laboratory and clinical studies tell us, so far. Acta Trop 2016; 162: 196-205.
[http://dx.doi.org/10.1016/j.actatropica.2016.06.026] [PMID: 27349189]
[102]
Mahmud MA, Chappell CL, Hossain MM, Huang DB, Habib M, DuPont HL. Impact of breast-feeding on Giardia lamblia infections in Bilbeis, Egypt. Am J Trop Med Hyg 2001; 65(3): 257-60.
[http://dx.doi.org/10.4269/ajtmh.2001.65.257] [PMID: 11561714]
[103]
Centers for Disease Control and Prevention. Giardia: Prevention and Control: General Public. Available at: https://www.cdc.gov/parasites/giardia/prevention-control-general-public.html (Accessed March 20, 2019)
[104]
Hogan RB. Product and method for treating diarrhea. US20190038619 (2019).
[105]
Rayan P. Treatment or prevention of giardiasis with a biologically active extract from Terminalia ferdinandiana fruit. WO2017063017 (2017).
[106]
Zhang S. Filtering recovery device related to Cryptosporidium and Giardia and filtering recovery system related to Cryptosporidium. WO201710948159 (2017).
[107]
Benyacoub J, Pérez PF, Rochat F, Saudan KY, Reuteler G, Antille N, et al. Enterococcus faecium SF68 enhances the immune response to Giardia intestinalis in mice. J Nutr 2005; 135(5): 1171-6.
[http://dx.doi.org/10.1093/jn/135.5.1171] [PMID: 15867299]
[108]
Humen MA, De Antoni GL, Benyacoub J, et al. Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun 2005; 73(2): 1265-9.
[http://dx.doi.org/10.1128/IAI.73.2.1265-1269.2005] [PMID: 15664978]
[109]
Bermudez-Humaran LG, Allain T, Florent I, et al. Compositions for inhibiting Giardia lamblia. US20170216415 (2017).
[110]
Fournier GP, Alm E. Methods and products related to protozoan disease. US20150166562 (2015).
[111]
Gregg JMH. Antimicrobial drug synthesis and therapeutic compositions. US20180311214 (2018).
[112]
Palomo-Ligas L, Gutiérrez-Gutiérrez F, Ochoa-Maganda VY, Cortés-Zárate R, Charles-Niño CL, Castillo-Romero A. Identification of a novel potassium channel (GiK) as a potential drug target in Giardia lamblia: Computational descriptions of binding sites. PeerJ 2019; 7e6430
[http://dx.doi.org/10.7717/peerj.6430] [PMID: 30834181]
[113]
Zheng W, Chen C, Marugan J, et al. Methods of treating giardiasis. US9173898 (2015).
[114]
Huang C. Fast detecting and source-tracing method for Cryptosporidium and Giardia lamblia in urban sewage. WO2017105892776 (2017).


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 2
Year: 2019
Page: [134 - 143]
Pages: 10
DOI: 10.2174/1872213X13666190618124901

Article Metrics

PDF: 42
HTML: 13